K233349

Substantially Equivalent

Alinity m HSV 1 & 2 / VZV

Applicant: Abbott Molecular, Inc.
Product code: PGI
Advisory panel: Microbiology
Date received: 2023-09-29
Decision date: 2024-05-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Des Plaines, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.